Partial
Partially Aligned
Patient Risk:
Medium
Summary
Some statements about zolpidem/AMBIEN identification and tablet appearance are supported by the provided label excerpts (strength/form appearance; complex sleep behaviors include sleep-walking). However, multiple claims about photo-based identification, counterfeit/mix-ups, unverified online photos, and formulation/manufacturer variability are not supported by the supplied excerpts and may be speculative beyond the label.
Category Scores
Accurate Statements
Ambien is a brand-name zolpidem.
Provided label excerpt: “AMBIEN (zolpidem tartrate) …”
Ambien tablets can vary in appearance by dose strength.
Provided label excerpt: AMBIEN 5 mg tablets are “capsule-shaped, pink…” with debossed “AMB 5” / “5401”; AMBIEN 10 mg tablets are “capsule-shaped, white…” with debossed “AMB 10” / “5421”.
Ambien pill identification from a photo can be confused by similar-looking pills from different drugs, especially among sleep medications.
Ambien-related unusual behaviors can include sleepwalking.
Provided label excerpt (Complex sleep behaviors): “Complex sleep behaviors including sleep-walking…”
Unsupported Statements
Ambien tablet appearance can vary by immediate-release versus other zolpidem formulations.
The provided label excerpts only describe AMBIEN 5 mg and 10 mg strength tablets and do not mention other zolpidem formulations or immediate-release vs non-immediate-release differences.
Ambien and zolpidem generics may look different.
The provided label excerpts describe AMBIEN tablet characteristics only; no labeling support is provided regarding generic manufacturers/substitution appearance.
Pill appearance can vary by manufacturer and generic substitution.
No labeling excerpt addresses generic substitution/manufacturer variability in appearance.
Ambien pill identification from a photo can be confused by similar-looking pills from different drugs, especially among sleep medications.
The provided excerpts do not discuss photo identification errors or confusion with other drugs.
Medication identification from a photo can be affected by counterfeit pills or packaging mix-ups.
The provided excerpts do not mention counterfeits or packaging mix-ups.
Using a photo from the wrong dose or formulation can lead to dangerous mix-ups when identifying medication.
The provided excerpts do not discuss mix-ups resulting from photo-based identification or “dangerous” outcomes due to photo mismatch.
Photos online about Ambien-related incidents are often unverified.
The provided excerpts do not discuss online photos or verification.
Contradictions
Important Omissions
The label excerpt includes that complex sleep behaviors may include sleep-driving and other activities while not fully awake, and recommends discontinuing AMBIEN immediately if a patient experiences a complex sleep behavior.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
Unsupported/speculative statements about photo-based identification, counterfeit/mix-ups, and unverified online incident photos could mislead users if treated as label-backed guidance. One supported behavioral risk statement (sleep-walking) aligns with the label.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Several claims extend beyond the provided prescribing information (photo identification, counterfeit/mix-ups, generic/manufacturer appearance variability, and unverified online photos) without label support.
Suggested Improvement
Limit statements to label-supported facts: AMBIEN is zolpidem tartrate; 5 mg (pink) vs 10 mg (white) tablet appearance details; and complex sleep behaviors including sleep-walking (plus sleep-driving and other activities) with discontinuation guidance if such events occur.